InforMatrix: ADP antagonists in acute coronary syndromes

Author： Janknegt Robert Ruiters Lex ten Cate Hugo

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.13, Iss.3, 2012-02, pp. : 357-385

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Matrix Metalloproteinases in Acute Coronary Syndromes: Current Perspectives

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 10, 2012-01 ,pp. : 1192-1205

Bentham Science Publishers

Access to resources Recommend Favorite

GPIIb-IIIa antagonists: upstream vs deferred use in acute coronary syndromes

Inpharma, Vol. 1, Iss. 1576, 2007-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

GPIIb-IIIa antagonists cost effective in acute coronary syndromes

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 499, 2006-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

GP IIb/IIIa receptor antagonists beneficial in acute coronary syndromes

Inpharma, Vol. 1, Iss. 1221, 2000-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Fondaparinux in acute coronary syndromes

By Chaturvedi Vivek Karthikeyan Ganesan

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 12, 2009-12 ,pp. : 1615-1623

Informa Healthcare

Access to resources Recommend Favorite